136 related articles for article (PubMed ID: 30365141)
1. Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.
Tang Y; Wu B; Huang S; Peng X; Li X; Huang X; Zhou W; Xie P; He P
Oncol Rep; 2019 Jan; 41(1):57-66. PubMed ID: 30365141
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
[TBL] [Abstract][Full Text] [Related]
3. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.
Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X
Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.
Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y
Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541
[TBL] [Abstract][Full Text] [Related]
7. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT.
Peng X; Guo W; Liu T; Wang X; Tu X; Xiong D; Chen S; Lai Y; Du H; Chen G; Liu G; Tang Y; Huang S; Zou X
PLoS One; 2011; 6(5):e20341. PubMed ID: 21647377
[TBL] [Abstract][Full Text] [Related]
8. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑106b functions as an oncogene and regulates tumor viability and metastasis by targeting LARP4B in prostate cancer.
Yin W; Chen J; Wang G; Zhang D
Mol Med Rep; 2019 Aug; 20(2):951-958. PubMed ID: 31173237
[TBL] [Abstract][Full Text] [Related]
10. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
11. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y
Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.
Fu Q; Liu X; Liu Y; Yang J; Lv G; Dong S
Int J Mol Med; 2015 Nov; 36(5):1417-25. PubMed ID: 26647850
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
[TBL] [Abstract][Full Text] [Related]
14. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling.
Li Q; Ye L; Zhang X; Wang M; Lin C; Huang S; Guo W; Lai Y; Du H; Li J; Song L; Peng X
Cancer Lett; 2017 Aug; 402():166-176. PubMed ID: 28602974
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
16. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
17. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
[TBL] [Abstract][Full Text] [Related]
18. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145.
Guo W; Ren D; Chen X; Tu X; Huang S; Wang M; Song L; Zou X; Peng X
J Cell Biochem; 2013 Jul; 114(7):1606-15. PubMed ID: 23355420
[TBL] [Abstract][Full Text] [Related]
19. The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.
Zhou Y; Ji Z; Yan W; Zhou Z; Li H
Oncol Rep; 2017 Sep; 38(3):1411-1419. PubMed ID: 28713997
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5.
Fan J; Du W; Zhang H; Wang Y; Li K; Meng Y; Wang J
FEBS Lett; 2020 Feb; 594(3):466-476. PubMed ID: 31562641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
